US survey - Financial reporting leaders' AI expectations for their companies and auditors in the Healthcare and Life Sciences industry.
100% of US financial reporting leaders surveyed report they expect to be using artificial intelligence (AI) in financial reporting within three years (up from 71% today), and 97% expect to be using generative AI (GenAI) (up from 46% today), according to the survey report, AI in Financial Reporting and Audit: Navigating the New Era. The聽global survey聽was conducted among 1,800 companies across ten major markets, including Healthcare and Life Sciences.
More detailed US findings for the Healthcare & Life Sciences industries are available in the聽full report.
Unlocking the value of Real-World Data in the era of Gen AI
How to capitalize on this dynamic opportunity for healthcare and life sciences at the intersection of RWD and GenAI.
The importance of Trusted AI in healthcare
Crafting the future of healthcare鈥檚 relationship with technology
2024 Healthcare and Life Sciences Investment Outlook
We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.
Healthcare and life sciences M&A: Poised for a rebound?
After a wild few years for HCLS, there鈥檚 reason for optimism and some new opportunities鈥攊f you know where to look.
GenAI is poised to transform healthcare. Is healthcare ready?
The fast-moving tech鈥檚 revolutionary potential promises to redefine a massive industry and its slow-mover history鈥攁nd the stakes have never been higher.